Average cost of drugs for extensively drug-resistant tuberculosis in Bhutan
Bhutan: Average cost of drugs for extensively drug-resistant tuberculosis was 2,259 constant 2022 US$ in 2024. ▼ Falling
Latest (2024)
2,259 constant 2022 US$
Change on year
unchanged
World rank
23rd
of 56 countries
All-time high
2,951 constant 2022 US$
in 2019
All-time low
2,259 constant 2022 US$
in 2020
Years of data
6
2019–2024
Average cost of drugs for extensively drug-resistant tuberculosis in Bhutan, 2019–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
The most recent figure for average cost of drugs for extensively drug-resistant tuberculosis in Bhutan is 2,259 constant 2022 US$, measured in 2024. That is the lowest value across all 6 years on record.
That represents a change of down 23.4% over ten years.
Bhutan ranks 23rd of 56 countries on this measure, in the middle of the range.
Average cost of drugs for extensively drug-resistant tuberculosis in Bhutan, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2019 | 2,951 constant 2022 US$ | — |
| 2020 | 2,259 constant 2022 US$ | -23.4% |
| 2021 | 2,259 constant 2022 US$ | +0.0% |
| 2022 | 2,259 constant 2022 US$ | +0.0% |
| 2023 | 2,259 constant 2022 US$ | +0.0% |
| 2024 | 2,259 constant 2022 US$ | +0.0% |
Bhutan compared with similar countries
- Bhutan's 2,259 constant 2022 US$ is above the median for lower middle income countries, which is 1,525 constant 2022 US$, 1.5× the median. (24 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,951 constant 2022 US$ | 2,951 constant 2022 US$ | 2,951 constant 2022 US$ | 1 |
| 2020s | 2,259 constant 2022 US$ | 2,259 constant 2022 US$ | 2,259 constant 2022 US$ | 5 |
Countries ranked near Bhutan
More reference data data for Bhutan
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.0217 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 0.0671 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 0.1192 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.0167 (2050)
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 0.1192 (2050)
- Emission Totals - Emissions (N2O) - Manure applied to Soils 0.0727 (2050)
- Emission Totals - Emissions (N2O) - Manure Management 0.0153 (2050)
- Emission Totals - Emissions (N2O) - Manure left on Pasture 0.3489 (2050)
- Emission Totals - Emissions (N2O) - IPCC Agriculture 0.5881 (2050)
- Emission Totals - Emissions (N2O) - Crop Residues 0.0909 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Bhutan?
- Average cost of drugs for extensively drug-resistant tuberculosis in Bhutan was 2,259 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Bhutan?
- The highest recorded value was 2,951 constant 2022 US$ in 2019.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Bhutan?
- The lowest recorded value was 2,259 constant 2022 US$ in 2020.
- How does Bhutan rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Bhutan ranks 23rd out of 56 countries with data for 2024.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Bhutan?
- Over the last ten years it is down 23.4%. The long-run trend across the full record is falling.
- Where does this Bhutan data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.